Original Source(s)
Related Content
Phase 3 Win for TED Therapy
Amgen’s subcutaneous TEPEZZA meets phase 3 endpoints in thyroid eye disease
May 8, 2026
-
3 min
Retinal Ischemia as Stroke Warning
Retrospective study investigates links between acute ischemic ocular events and increased stroke risk
May 8, 2026
-
3 min
Vamikibart Shows Early Safety in Uveitic Macular Edema
Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven
by Kerri Miller
May 7, 2026
-
3 min